About The Condition
Understanding Wet AMD
Wet age-related macular degeneration (AMD) is a progressive retinal condition that may be associated with changes in central vision, and in some cases, progression over time.
It occurs when abnormal blood vessels grow beneath the macula, leading to leakage, swelling, and damage to central vision.
Early detection and timely treatment are essential to stabilizing the condition and preserving visual function.
WHY EARLY REFERRAL MATTERS
Why Referral for Suspected Wet AMD is important
Wet AMD can be associated with changes in central vision. Early assessment may help guide diagnosis and management. Prompt referral may support:
- Confirmation of diagnosis
- Access to retinal imaging
- Determination of appropriate management
Patients are assessed within clinically appropriate timeframes based on referral information and presenation.
SIGNS & SYMPTOMS
When to Refer A Patient for nAMD
Consider referral for retinal assessment in patients with:
- New distortion (metamorphopsia) or central visual changes
- Unexplained decrease in central vision
- Suspicion of choroidal neovascularization
- OCT findings suggestive of subretinal or intraretinal fluid
- New hemorrhage or exudation in the macula
- Rapid change in vision in patients with known AMD
nAMD can progress over a short period. Patients with new symptoms may benefit from prompt assessment.
Delivered through Precision Retina Care
How We Manage Wet AMD
Wet AMD is managed through a structured clinical approach that combines advanced imaging, individualized treatment planning, and ongoing monitoring. Care includes:
- Comprehensive retinal evaluation
- Multi-modal retinal imaging (OCT and related technologies)
- Diagnosis confirmation and disease staging
Treatment may include intravitreal anti-VEGF therapy with frequency and approach individualized based on the patient’s condition and response over time.
Patients are assessed and managed by Dr. Varun Chaudhary in Hamilton. Care is delivered using a structured clinical approach (Precision Retina Care, PRC) to support timely access and coordination of care.
RAPID ACCESS MODEL
Structured Access for Patients with Wet AMD
Dr. Varun Chaudhary provides clinical care through Precision Retina Care (PRC), with coordinated access for patients with suspected neovascular (wet) AMD who may require timely assessment given the potential for changes in central vision. At Precision Retina Care:
- Referrals are reviewed and triaged based on clinical information
- Patients are contacted directly for coordination
- Assessment and treatment are arranged within clinically appropriate timeframes
This approach is intended to support access to retinal evaluation based on individual patient needs.
Need Help or Want to Learn More?
Frequently Asked Questions About Wet AMD
What is the difference between dry and wet AMD?
Dry AMD progresses more slowly and is more common, while wet AMD involves abnormal blood vessel growth and can lead to rapid vision loss, requiring urgent treatment.
How quickly should a patient be referred?
Patients with suspected wet AMD should be referred as soon as possible, especially if symptoms are new or worsening.
What happens after a referral is sent?
The clinic contacts the patient directly to schedule an appointment. Referring providers are kept informed of appointment details and care updates.
Please indicate “PRC” on the referral so the clinic team can prioritize the intake process. Patients will be contacted directly, and referring offices will receive confirmation of the appointment.
What treatments are available for wet AMD?
The primary treatment is anti-VEGF therapy, which helps reduce fluid and control abnormal blood vessel growth. Treatment is individualized based on response.
Will patients need ongoing care?
Yes. Wet AMD typically requires long-term monitoring and repeat treatments to maintain stability.
Can patients participate in clinical trials?
Some patients may be eligible for clinical trials evaluating new therapies. Eligibility depends on specific study criteria.